# A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)

> **NCT02364752** · PHASE1 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Heart Failure

## Interventions

- **PROCEDURE:** Blood Draw
- **PROCEDURE:** Loop Diuretic Withdrawal/Salt Load

## Key facts

- **NCT ID:** NCT02364752
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2016-03
- **Final completion:** 2016-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364752, "A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02364752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*